← Back
Rare Disease

Givinostat (Duvyzat)

Italfarmaco / Chiesi

HDAC inhibitor. FDA approved February 2024. First small molecule for all DMD genotypes. Post-marketing studies ongoing.

Duchenne Muscular Dystrophy

Linked Studies

NCT05096221PrimaryCOMPLETEDPHASE3

A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)

Duchenne Muscular DystrophyUpdated Jul 2025
Loading comments…

Also Known As

Other names

givinostat
Search all trials →Request coverage update